42.7 million mental health-related medications were dispensed in 2020–21.
4.5 million patients (17.7% of the Australian population) filled a prescription for a mental health-related medication in 2020–21, with an average of 9.4 prescriptions per patient.
I further estimate 1/3 are definable as treatment resistant, so 1.5 Million patients in Australia who would become potential patients for Emyria program for treatment resistant conditions.
A suicidal ideation treatment program with ketamine is in the pipeline in the USA, Project 2025.
Competition is Monarch Mental Health Group, Ramsay Health Care, ReviveMed, others.
general talk, page-297
Add EMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.81M | |||
| Open | High | Low | Value | Volume |
| 4.6¢ | 4.6¢ | 4.6¢ | $5.42K | 117.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 327799 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 63337 | 2 |
View Market Depth
| Last trade - 13.31pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
4.6¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 4.6¢ | 4.6¢ | 4.6¢ | 65562 | ||
| Last updated 14.31pm 17/06/2024 ? | |||||
| EMD (ASX) Chart |
